Assessment of methylsulfonylmethane as a permeability enhancer for regional EDTA chelation therapy Methylsulfonylmethane as a permeability enhancer Min Zhang et al.

Drug Delivery

Volumn 16, Issue 5, 2009, Pages 243-248

  Zhang, Min ^a   Wong, Ira G ^b,c   Gin, Jerry B ^c   Ansari, Naseem H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Chakshu Research   (United States)

Author keywords

Chelation therapy; Ciprofloxacin; Ethylenediaminetetraacetic acid (EDTA); Metal chelation; Methylsulfonylmethane (MSM); Permeability enhancers

Indexed keywords

CARBON 14; CIPROFLOXACIN; DIMETHYL SULFONE; EDETIC ACID; PENETRATION ENHANCING AGENT; CHELATING AGENT; DIMETHYL SULFOXIDE; RADIOISOTOPE; SULFONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CHELATION; CHELATION THERAPY; CONTROLLED STUDY; CORNEA; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TRANSPORT; DRUG UPTAKE; INTESTINE ABSORPTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD BRAIN BARRIER; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; EYE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD-BRAIN BARRIER; CHELATING AGENTS; CHELATION THERAPY; CORNEA; DIMETHYL SULFOXIDE; DRUG SYNERGISM; EDETIC ACID; EYE; MALE; RADIOISOTOPES; RATS; RATS, SPRAGUE-DAWLEY; SULFONES;

EID: 70349308247     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540902896362     Document Type: Article

References (22)

1. Andersen, O. (2004). Chemical and biological considerations in the treatment of metal intoxication by chelating agents. Mini Rev Med Chem. 4, 11-21.
2. Andersen, O., Aaseth, J. (2002). Molecular mechanisms of in vivo metal chelation: implications for clinical treatment of metal intoxications. Environ Health Persp. 110 (suppl 5), 887-890
3. Barrow, D.J. Jr., Chandrasekaran, S., Heerklotz, H.H., Henary, M.M., Michniak, B.B., Nguyen, P.M., Song, Y., Smith, J.C., Strekowski, L. (2005). Mechanistic studies on percutaneous penetration enhancement by N-(4-halobenzoyl)-S,Sdimethyliminosulfuranes. J Lipid Res. 46, 2192-2201
4. Blanusa, M., Varnai, V.M., Piasek, M., Kostial, K. (2000). Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr Med Chem. 12, 2771-2794
5. Chandrasekaran, S.K., Shaw, J.E. (1978). Factors influencing the percutaneous absorption of drugs. Curr Probl Dermatol. 7, 142-155
6. Dimitrijevic, D., Shaw, A.J., Florence, A.T. (2000). Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells. J Pharm Pharmacol. 52, 157-162
7. Eley, J.G., Triumalashetty, P. (2001). In vitro assessment of alkyglycosides as permeability enhancers. AAPS PharmsciTech. 2, 1-7.
8. Grass, G.M., Wood, R.W., Robinson, J.R. (1985). Effect of calcium chelating agents on corneal permeability. IOVS. 26, 110-113
9. He, X., Hahn, P., Iacovelli, J., Wong R, King C, Bhisitkul R, Massaro- Giordano M, Dunaief JL. (2007). Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res. 26, 649-673
10. Horváth, K., Noker, P.E., Somfai-Relle, S., Glávits, R., Financsek, I., Schauss, A.G. (2002). Toxicology of methylsulfonylmethane in rats. Food Chem Toxicol. 40, 1459-1462
11. Jayasena, T., Grant, R.S., Keerthisinghe, N., Solaja, I., Smythe, G.A. (2007). Membrane permeability of redox active metal chelators: an important element in reducing hydroxyl radical induced NAD+ depletion in neuronal cells. Neurosci Res. 57, 454-461
12. Kalinowsky, D.S., Richardson, D.R. (2005). The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev. 57, 547-583
13. Liu, G., Men, P., Harris, P.L., Rolston, R.K., Perry, G., Smith, M.A. (2006). Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurological disorders associated with trace metal imbalance. Neurosci Lett. 406, 189-193
14. Magnuson, B.A., Appleton, J., Ames, G.B. (2007). Pharmacokinetics and distribution of (35S) methylsulfonylmethane follow oral administration to rats. J Agric Food Chem. 55, 1033-1038
15. Meaney, C.M., O'Driscoll, C.M. (2000). A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt:fatty acid micellar systems using the CaCo-2 cell culture model. Int J Pharm. 207, 21-30.
16. Najjar, D.M., Cohen, E.J., Rauan, C.J., Laaibson, P.R. (2004). EDTA chelation for calcific band keratopathy: results and long-term follow-up. Am J Ophthalmol. 137, 1056-1064
17. Ouyang, H., Morris-Natschke, S.L., Ishaq, K.S., Ward, P., Liu, D., Leonard, S., Thakker, D.R. (2002). Structure-activity relationship for enhancement of paracellular permeability across Caco-2 cell monolayers by 3-alkylamido-2-alkoxypropylphosphocholines. J Med Chem. 45, 2857-2866
18. Quan, Y.S., Hattori, K., Lundborg, E., Fujita, T., Murakami, M., Muranishi, S., Yamamoto, A. (1998). Effectiveness and toxicitiy screening of various absorption enhancers using Caco-2 cell monolayers. Biol Pharm Bull. 21, 615-620
19. Sakai, M., Imai, T., Ohtake, H., Otagiri, M. (1998). Cytotoxicity of absorption enhancers in Caco-2 monolayers. J Pharm Pharmacol. 50, 1101-1108
20. Smith, J., Wood, E., Dornish, M. (2004). Effect of chitosan on epithelial cell tight junctions. Pharm Res. 21, 43-49
21. Swenson, E.S., Milisen, W.B., Curatolo, W. (1994). Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm Res. 11, 1132-1142
22. Uchiyama, T., Yamamoto, A., Hatano, H., Fujita, T., Muranishi, S. (1996). Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane. Biol Pharm Bull. 19, 1618-1621